Study to detect and prevent early stomach cancer
Part of Cancer, Digestive system clinical trials.
This study looks for early warning changes in the stomach and aims to improve early detection and prevention. Depending on your situation, you may be grouped as having stomach symptoms, early lesions that might be removed, already-diagnosed stomach cancer, or a comparison group without stomach problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (age 18 or older).
- You must be able to have an endoscopy (“camera” exam of the stomach) and possibly stomach biopsies (small tissue samples).
- You may qualify only if you fit one of the study groups: symptoms needing diagnostic endoscopy, certain early lesions needing endoscopic removal, already-diagnosed stomach cancer, or a control group without gastric issues/family history.
- For the EDGAR 1 group, you must not have had a previous diagnosis of pre-cancer polyps (PGLs) and must not have had prior stomach surgery.
- For the EDGAR 2 group, you must be eligible for endoscopic removal (resection) and biopsies if needed.
- For the EPIGASTRIC group, your cancer must be stomach adenocarcinoma (a specific type of stomach cancer), not another type of stomach tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.